dual TIGIT checkpoint inhibitor/PD-1 checkpoint inhibitor (Alpine Immune Sciences)

N/A

Report date: 2025/03/18 18:15:29

Base Information

Drug Namedual TIGIT checkpoint inhibitor/PD-1 checkpoint inhibitor (Alpine Immune Sciences)

Drug Alias Namemultiple vIgD Fc fusion (Alpine Immune Sciences)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionProgrammed cell death protein 1 blockersT cell immunoglobulin and ITIM domains inhibitors

TargetsT cell immunoglobulin and ITIM domainsProgrammed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAlpine Immune Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesAlpine Immune Sciences Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A